Products & ReviewClinical Diagnostics

CD-Chex CD103 Plus®

StreckAvailable: Worldwide

CD-Chex CD103 Plus is a positive flow cytometry control for CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda expression.  

Streck

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our  Product Directory.

Ease of Use
After Sales Service
Value for Money
Write your own review

CD-Chex CD103 Plus is a ready-to-use control for evaluating CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda expression by flow cytometry. This control provides assay values for two distinct abnormal leukocyte populations: CD45+ and CD45-. The CD45+ abnormal lymphocyte population contains multiple markers designated as “rare flow antigens” by CAP, including CD30 and CD103.

CD-Chex CD103 is designed to monitor reagent staining, erythrocyte lysis, sample preparation and instrument performance and is compatible with BD® Biosciences and Beckman Coulter® flow cytometry systems.

Features

  • Only commercially available control assayed for CD103, CD30, CD38, CD56, CD138 and cytoplasmic Lambda
  • Two distinct abnormal leukocyte populations: CD45+ and CD45-
  • Compatible with BD Biosciences and Beckman Coulter flow cytometry systems
  • 30-day open-vial stability; 90-day closed-vial stability

Benefits

  • Helps clinical laboratories meet quality requirements for leukemia and lymphoma immunophenotyping
  • Manufacturer established assay ranges – no need to verify range per CAP requirements
  • Eliminates the need for labs to hold and validate patient samples for use as a control
  • Access to STATS®, Streck’s free interlaboratory quality control program for peer group data comparison
  • For Research Use Only. Not for use in diagnostic procedures.

Product Overview

Links